Work

Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.7061

Authors: V. A. Miller, R. Herbst, D. Prager, L. Fehrenbacher, R. Hermann, P. Hoffman, B. Johnson, A. B. Sandler, M. G. Kris, D. Ramies

Institutions: Memorial Sloan Kettering Cancer Center, Kaiser Permanente, Genentech, Ronald Reagan UCLA Medical Center, UCLA Medical Center, University of Chicago, Kaiser Permanente Vallejo Medical Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2246399377

Cites:

Cited by: 51

Related to: 10